Both in Pharmaceuticals
Lifevantage Corporation Common Stock (Delaware) vs Coya Therapeutics
Over the past year LFVN returned −14.7% and COYA returned −47.4%; their daily moves had a correlation of 0.07.
LFVN −14.7% COYA −47.4%Growth of $1, one year, split-adjusted
| Metric | LFVN | COYA |
|---|---|---|
| Price | $5.97 | $3.08 |
| Market cap | $75.2M | $72.3M |
| Today | +3.65% | −0.96% |
| 1 month | −1.2% | −36.5% |
| 6 months | −0.5% | −27.4% |
| Year to date | −3.1% | −46.9% |
| 1 year | −18.7% | −48.7% |
| Revenue growth (YoY) | −23.1% | +49.0% |
| Gross margin | 78.0% | 100.0% |
| Net margin | 3.0% | −2723.4% |
| P/E (TTM) | 14.8× | — |
| Price / sales | 0.4× | 9.0× |
| Net cash | $14.9M | $43.2M |
| Dividend yield | 3.35% | — |
| Volatility (60d) | 26.1% | 56.9% |
| Short % of float | 9.5% | 7.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).